Performance funds/ETFs
Janus Henderson | Janus Henderson Global Life Sciences Fund Acc
The Fund invests at least 80% in shares of companies of any size, with a life sciences orientation, in any country.The Fund may also invest in other assets including cash and money market instruments.The investment manager looks to identify innovative healthcare companies addressing high unmet medical needs across fields including biotechnology,pharmaceuticals, healthcare services and medical technology
Growth in fund currency
Available documents (NL)
Available documents (EN)
Available documents for this product 
Quote
Quote
€33,00
Quote date
31-03-2026
Performance in EUR
Date
31-03-2026
This year
-2,25%
1 week
3,09%
1 month
-4,43%
3 months
-2,25%
6 months
15,99%
1 year
11,04%
3 years (annualised)
8,00%
5 years (annualised)
7,40%
Since start (annualised)
11,00%
Indicators
Standard deviation (3yr)
15,00%
Share ratio (3yr)
0,39
Beta (3yr)
1,14
Alpha (3yr)
4,65
Tracking error (3yr)
5,57
Top 10 holdings (28-02-2026)
Eli Lilly and Co
9,38 %
Johnson & Johnson
6,93 %
AstraZeneca PLC
4,62 %
AbbVie Inc
3,84 %
UnitedHealth Group Inc
3,13 %
Novartis AG ADR
2,96 %
Abbott Laboratories
2,55 %
Roche Holding AG
2,50 %
Praxis Precision Medicines Inc Ordinary Shares
2,41 %
argenx SE ADR
2,37 %
Fees
Entry fee
0.20%
Exit charges
0.20%
Estimated ongoing charges
0,86%
Dividend
Dividend paying
No
Characteristic
Asset Manager
Janus Henderson
Asset class
Equities
Investment category
Equities - Healthcare
Active/Passive
Active
Fund code
96003
Fund code fractional orders
96003
Fund manager name
Daniel Lyons|Andy Acker
ISIN
IE00BRJG7840
Sustainable Classification
Art. 8, ESG integration
Sustainability Rating
Domicile
Ireland
Currency
EUR
Fund size (mio)
€3.993,41 (30-03-2026)
Cut-off time
-
Execution date
Yes
Inception date
20-10-2014
Benchmark
MSCI World/Health Care NR USD
Minimum investment amount
€20
Assortiment
Self Directed Investing Plus, Investment advice